On Wednesday, in a statement Pfizer Inc said, it has decided to stop producing biosimilar products in China; it has also decided to sell one of its business unit in the eastern city of Hangzhou to WuXi Biologics Inc. “The… Read More ›
costly
Italy commences discussions over GACS scheme renewal
Although risk premiums for the GACS scheme are pricey for the Italian government, but given its size of 100 billion euros, the Italian government is likely to be hard pressed on ways to significantly trim it no matter how complicated… Read More ›
Britain’s competition authority likely to rule on Sainsbury’s-Asda $66 billion merger in early March
With Britain’s Competition and Markets Authority taking on a more active interventional approach in its latest ruling, the Sainsbury’s-Asda deal, which could create Britain’s biggest retailer, faces headwinds from multiple angles. Although Mike Coupe, Asda’s CEO was taped on camera… Read More ›
MiFID II increasing pressure on margins on mid-to-small brokerages
Although regulators introduced MiFID II in order to bring about increased transparency and ensure that investors get a fairer deal, but with the reduced cost of market research, the market dominance by large financial institution is quickly becoming an issue…. Read More ›
manageria.biz 